Company

Future-driven neurotechnology

Phantom Neuro is a future-driven neurotechnology company, spun out of Johns Hopkins University School of Medicine. We are creating the world’s first minimally invasive muscle-machine interface for the control of robotic prosthetic limbs, robotic exoskeletons, and beyond.

Our Objective

Phantom Neuro is driven to help amputees and individuals with limb deficits regain control of their lives.

Our minimally invasive system offers life-like control of robotic orthopedic technologies, including prosthetic arms, legs, and exoskeletons.

The Phantom Neuro Team

Phantom Neuro’s team is comprised of the best and brightest minds at the forefront of medical innovation.

The combination and our team’s unique backgrounds and our user-centric decision making furthers our mission to enhance people’s lives.

Leadership

Connor Glass

Connor Glass

President & CEO

D.A. Wallach

D.A. Wallach

Director

Ed Michael

Ed Michael

Director

Technical Advisors

Sami Tuffaha, MD

Sami Tuffaha, MD

Director of Nerve Surg

Tom Oxley, MD, PhD

Tom Oxley, MD, PhD

Founder & CEO: Synchron

Geoff Ling, MD, PhD

Geoff Ling, MD, PhD

Founding Director: DARPA BTO

Nitish Thakor, PhD

Nitish Thakor, PhD

Director of Laboratory for Neuroengineering: Johns Hopkins

Josh Duyan

Josh Duyan

Former CSO: CTRL labs

Limb Injury Advisors

Olivia Jackson

Olivia Jackson

(Upper Limb Amputee)
Former Hollywood Stuntwoman

Johnny Matheny

Johnny Matheny

(Upper Limb Amputee)
Professional Bionics Research Participant

Nick Lavery

Nick Lavery

(Lower Limb Amputee)
Green Beret, Author, Motivational speaker

Clint Trial

Clint Trial

 (Bilateral Lower Limb Amputee)
Former Special Forces, Current Board of Black Rifle Coffee

Sam Cila Upper

Sam Cila Upper

 (Limb Amputee)
Former Special Forces, Current Motivational Speaker, Ironman, and Competitive Weightlifter

Investors

We have currently raised $9.5 million in seed funding from institutional and strategic investors, including: 

Lead Investor Series Seed 2
Lead Investor Series Seed

Risk & Return Ventures

Get Connected

Subscribe to receive updates on product launch and news.

This field is for validation purposes and should be left unchanged.

Copyright © 2023. All Rights Reserved.